CRMD — CorMedix Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1410098 ·
Last close
$7.85
Market Cap
$611.86M
52W High
$13.02
52W Low
$6.13
ADV30
1,069,810
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 99,307,000 | 74,502,000 | 42,910,000 | 25,988,000 | 904,052,000 | 256,692,000 | 443,219,000 |
| Mar 2026 | 127,427,000 | 105,122,000 | 63,658,000 | 38,601,000 | 815,637,000 | 178,087,000 | 378,588,000 |
| Dec 2025 | 128,615,264 | 107,308,042 | 59,126,248 | 14,020,141 | 826,142,000 | 144,837,000 | 420,835,000 |
| Sep 2025 | 104,275,289 | 93,080,673 | 51,345,966 | 108,562,980 | 750,861,478 | 48,493,076 | 376,732,072 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$197,691,000
Investing CF
$-305,270,000
Financing CF
$220,263,000
CapEx
$-2,979,000
Dividends Paid
—
Buybacks
$-11,092,000
EPS Diluted TTM
$2.13
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-137,974,000
Inventory
$30,731,000
Receivables
$154,807,000
ST Investments
$0
EBIT TTM
$195,802,094
Pretax Income TTM
$185,017,102
Interest Exp TTM
$2,781,999
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$462,248,992
EBITDA
$262,548,000
Free Cash Flow
$178,142,656
Enterprise Value
$500,677,344
Total Cash
$256,692,000
Total Debt
$147,455,008
Shares Out
77,944,324
Trailing EPS
$2.18
Book Value
$5.93
ROE
54.9%
ROA
24.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 311,709,000 | 150,141,000 | 163,055,000 | 826,142,000 | 420,835,000 | 405,307,000 | 175,046,000 |
| Dec 2024 | 43,472,000 | -22,356,000 | -17,930,000 | 118,846,000 | 34,189,000 | 84,657,000 | -50,615,000 |
| Dec 2023 | 0 | -48,957,788 | -46,339,227 | 82,059,957 | 11,917,528 | 70,142,429 | -38,409,480 |
| Dec 2022 | 65,408 | -30,623,968 | -29,701,705 | 62,038,259 | 6,978,523 | 55,059,736 | -24,356,732 |
TTM Snapshot
Revenues TTM
$39,082,000
NetIncome TTM
$20,644,000
OpCashFlow TTM
$0
Assets (Latest)
$826,142,000
Forward EPS
$0.35
Max Pain — expiry 2027-01-15
max pain strike: $8.00 · spot: $7.89 · call oi: 6,806 · put oi: 1,607
Expected Move to 2027-01-15:
±$1.60
(20.28%) —
implied range
$6.29 –
$9.49
· ATM straddle on $8.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IBO | IMPACT BIOMEDICAL INC. | $613.50M | $5.69 | — |
| STTK | Shattuck Labs, Inc. | $609.20M | $6.07 | — |
| ALT | Altimmune, Inc. | $595.22M | $3.06 | — |
| PHAT | Phathom Pharmaceuticals, Inc. | $590.58M | $7.30 | — |
| CTMX | CytomX Therapeutics, Inc. | $588.33M | $2.70 | — |
News headlines (Yahoo Finance, 1h cache)
CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged
2026-09-08 02:45 · Yahoo
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
2026-09-01 12:30 · Yahoo
CorMedix (CRMD) Upgraded to Buy: Here's Why
2026-08-31 16:00 · Yahoo
CorMedix (CRMD) Q2 2026 Earnings Call Transcript
2026-08-20 14:14 · Yahoo
Wall Street Analysts Believe CorMedix (CRMD) Could Rally 65.96%: Here's is How to Trade
2026-08-20 13:55 · Yahoo
Cormedix Inc (CRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised EBITDA ...
2026-08-13 23:08 · Yahoo
CorMedix Q2 Earnings Call Highlights
2026-08-13 15:06 · Yahoo
CorMedix CEO Expects Supplemental Filing For Fungal Disease Treatment By Q3 – CRMD Stock Sees Best Day In Nearly 10 Months After Earnings Beat
2026-08-13 15:04 · Yahoo
CorMedix (CRMD) Q2 Earnings and Revenues Top Estimates
2026-08-13 12:45 · Yahoo
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-13 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.